The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems

被引：0
|
作者：
Tricklebank, MD [1 ]
机构：
[1] MERCK SHARP & DOHME RES LABS, NEUROSCI RES CTR, HARLOW CM20 2QR, ESSEX, ENGLAND
来源：
BEHAVIOURAL BRAIN RESEARCH | 1996年 / 73卷 / 1-2期
关键词：
5-HT; dopamine; receptor subtype; mesolimbic; clozapine; schizophrenia;
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
Many neurochemical, electrophysiological and behavioural studies have shown how 5-HT and dopamine neuronal systems are able to interact and it is highly likely that the therapeutic benefits of clozapine-like atypical antipsychotic drugs are achieved by the modulation of such interactions. There are, however, at least fourteen subtypes of 5-HT receptor and five subtypes of dopamine receptor expressed in rodent and/or human brain and the optimum combination of receptor affinities required for maximum therapeutic benefit remains enigmatic.
引用
收藏
页码：15 / 17
页数：3
相关论文
共 50 条
  • [1] Therapeutic potential of subtype-selective GABA-A receptor ligands
    Reynolds, DS
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A5 - A5
  • [2] Development of subtype-selective nicotinic receptor ligands as receptor antagonists at the dopamine-releasing receptor subtype.
    Crooks, PA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U911 - U911
  • [3] Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands
    Schaab, Carolin
    Kling, Ralf Christian
    Einsiedel, Juergen
    Huebner, Harald
    Clark, Tim
    Seebach, Dieter
    Gmeiner, Peter
    CHEMISTRYOPEN, 2014, 3 (05): : 206 - 218
  • [4] 5-HT6 RECEPTOR LIGANDS AND THEIR ANTIPSYCHOTIC POTENTIAL
    Arnt, Jorn
    Olsen, Christina Kurre
    PHARMACOLOGY OF 5-HT6 RECEPTORS, PT II, 2011, 96 : 141 - 161
  • [5] Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat
    Kalkman, HO
    Neumann, V
    Nozulak, J
    Tricklebank, MD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (2-3) : 201 - 207
  • [6] Therapeutic potential of non-competitive, subtype-selective metabotropic glutamate receptor ligands
    Mutel, V
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (12) : 1845 - 1852
  • [7] SUBTYPE-SELECTIVE CHOLECYSTOKININ RECEPTOR ANTAGONISTS BLOCK CHOLECYSTOKININ MODULATION OF DOPAMINE-MEDIATED BEHAVIORS IN THE RAT MESOLIMBIC PATHWAY
    CRAWLEY, JN
    JOURNAL OF NEUROSCIENCE, 1992, 12 (09): : 3380 - 3391
  • [8] DOPAMINE UPTAKE INHIBITORY ACTIVITY OF NOVEL TRYPTAMINE 5-HT, RECEPTOR LIGANDS
    LEBEL, LA
    NOWAKOWSKI, JT
    MACOR, JE
    FOX, CB
    KOE, BK
    DRUG DEVELOPMENT RESEARCH, 1994, 33 (04) : 413 - 421
  • [9] EFFECTS OF 5-HT RECEPTOR SUBTYPE-SELECTIVE DRUGS ON LOCOMOTOR-ACTIVITY AND MOTOR HABITUATION IN THE DHT ADULT-RAT MODEL
    PRANZATELLI, MR
    JAPPAY, E
    SNODGRASS, SR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (03) : 497 - 504
  • [10] Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders
    Zhang, Ao
    Neumeyer, John L.
    Baldessarini, Ross J.
    CHEMICAL REVIEWS, 2007, 107 (01) : 274 - 302
12345